Recent Activity

Loading...

SBIO

ALPS Medical Breakthroughs ETF · PSE

  • Category Equity
  • Expense Ratio 0.5%
  • Listing Date Dec 31, 2014
  • Volume 3,585.0
  • Market Cap (AUM) $111.42M

Performance

+5.75%

1W

+2.48%

1M

+1.4%

3M

+36.67%

6M

+5.7%

YTD

+8.67%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Viking Therapeutics, Inc.VKTX5.12%
  • Cerevel Therapeutics Holdings IncCERE4.98%
  • Vaxcyte, Inc.PCVX4.50%
  • Revolution Medicines, Inc.RVMD4.16%
  • Alpine Immune Sciences, Inc.ALPN2.73%
  • Alkermes Public Limited CompanyALKS2.57%
  • Crinetics Pharmaceuticals IncCRNX2.35%
  • Axsome Therapeutics, Inc.AXSM2.27%
  • Xenon Pharmaceuticals Inc.XENE2.09%
  • Springworks Therapeutics, Inc.SWTX2.06%

Technical Analysis of SBIO 2024-05-03

Overview:

In analyzing the technical indicators for SBIO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Indicators...

See more ...

Recent News & Updates